Skip to main content
Erschienen in: Journal of Neurology 11/2014

Open Access 01.11.2014 | Letter to the Editors

Late onset hereditary sensory and autonomic neuropathy with cognitive impairment associated with Y163X prion mutation

verfasst von: Andreas C. Themistocleous, Robin Kennett, Masud Husain, Jacqueline Palace, Simon Mead, David L. H. Bennett

Erschienen in: Journal of Neurology | Ausgabe 11/2014

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN
Dear Sirs,
A 69-year-old male presented with a 16-year history of numbness and paraesthesia of both feet and symptomatic postural hypotension. He reported episodes of painless thermal injuries to his limbs and lower urinary tract symptoms including reduced urinary flow, frequency, nocturnal incontinence and recurrent urinary tract infections. There was a long history of diarrhoea which preceded his sensory symptoms by 10 years and resulted in 20 kg of weight loss, and increasing memory difficulties with greatest difficulty in recalling recent events. His mother had suffered from symptomatic postural hypotension and foot ulceration developing in her sixth decade; she died in her seventh decade. It is not known whether she suffered from chronic diarrhoea or cognitive impairment. He has two brothers whom are unaffected.
Blood pressure was 156/92 lying and 79/53 standing. On neurological examination, cranial nerves were normal and there was mild wasting of the intrinsic foot muscles more marked on the right than the left. Tone and motor strength was normal. On sensory examination, pinprick was reduced to the mid-calf bilaterally, vibration sense was reduced to the knees, light touch to the ankles and joint position sense was reduced at the hallux. His ankle jerk reflexes were absent. His gait was hesitant. He was unable to perform tandem gait and Romberg’s sign was positive.
Neurophysiological studies are summarised in Table 1 and showed a length-dependant predominantly axonal motor and sensory peripheral neuropathy with subtle demyelinating features. Cognitive testing revealed impairment with major deficits, most prominently in memory and executive function. Table 2 summarises all remaining investigations. Of note is the absence of any evidence of systemic amyloid.
Table 1
Summary of neurophysiological studies
Motor studies
1997
2013
Right
Left
Right
Left
Nerve
 Tibial
  Latency (ms)
5.8
5.4
 
6.5
  Amplitude (mV)
0.8
1.1
 
0.05
  Conduction velocity m/s
36
36
  
  F Wave (max) ms
65.5
Absent
 
Absent
 Peroneal
  Latency (ms): ankle
   
5.45
  Amplitude (mV): ankle
   
0.3
  Amplitude (mV): above knee
   
0.3
  Conduction velocity (m/s)
   
30.5
  F Wave (max) ms
   
Absent
 Ulnar
  Latency (ms): wrist
  
3.30
 
  Amplitude (mV): wrist
  
11.7
 
  Amplitude (mV): above elbow
  
9.6
 
  Conduction velocity (m/s)
  
45.6
 
  F Wave (min) ms
  
33.15
 
 Median
  Latency (ms): wrist
4.3
3.90
3.75
 
  Amplitude (mV): wrist
18.8
16.0
14.9
 
  Amplitude (mV): elbow
17.3
14.8
7.1
 
  Conduction velocity (m/s)
52
48
43.3
 
  F Wave (min) ms
  
34.25
 
Sensory studies
1997
2013
Right
Left
Right
Left
Nerve
 Sural
  Latency (peak) ms
Absent
Absent
Absent
Absent
  Amplitude (peak–peak) µV
Absent
Absent
Absent
Absent
 Radial
  Latency (onset) ms
  
1.90
 
  Latency (peak) ms
2.80
2.80
2.60
 
  Amplitude (peak–peak) µV
10.0
10.0
0.26
 
  Conduction velocity (onset) m/s
  
44.7
 
 Ulnar
  Latency (peak) ms
3.0
3.4
Absent
Absent
  Amplitude (peak–peak) µV
3.1
1.0
Absent
Absent
 Median
  Latency (peak) ms
4.10
4.10
Absent
Absent
  Amplitude (peak–peak) µV
2.20
2.10
Absent
Absent
Electromyography
1997
2013
Muscle
  Right tibialis anterior
No spontaneous activity, Normal pattern of motor unit recruitment with motor units up to 2.5 mV
No abnormal spontaneous activity. Voluntary recruitment moderately severely reduced in density with an excess of slightly unstable irregular motor unit potentials: durations up to 20 ms, amplitude up to 10 mV
  Right first dorsal interosseous
No spontaneous activity, Normal pattern of motor unit recruitment with motor units up to 2.5 mV
 
The neurophysiological studies were consistent with a length-dependant predominantly axonal motor and sensory peripheral neuropathy. However, the slowing of the conduction velocities, prolonged F waves and conduction block of the median nerve suggest a possible demyelinating component. Sympathetic skin response (performed only in 2013) was absent in the right hand and left foot
Bold values indicate abnormal results
ms milliseconds, mV millivolt, m/s metres per second, µV microvolt
Table 2
Summary of relevant investigations
Blood tests
 Hb 11 g/dl, WBC 5.34 × 109/L, platelets 119 × 109/L, MCV 101.5 fl, neutrophils 3.56 × 109/L
 Clotting screen normal
 Urea 10.1 µmol/L, creatinine 151 µmol/L, eGFR 41 ml/min
 Albumin 37 g/L
 Liver function tests normal
 IgA 2.2 g/L, IgG 9.8 g/L, IgM 1.2 g/L, no serum paraprotein detected
 Serum free light chains: Kappa 26.8 mg/L, Lambda 20.9 mg/L. K/L ratio 1.28
 Lipid profile normal
 CRP <1 mg/L
 NT- pro BNP 129pMol/L
 Cardiac Troponin 0.015T ng/mL
Urine
 Creatinine clearance 35.6 ml/min
 24 h urinary protein loss 0.31 g
 Bence Jones protein not detected
Genetic testing
 PMP22 duplication/deletion negative
 Transthyretin, SPTLC1, Rab7 sequencing negative
Amyloid deposition investigations
 SAP Scan: no visceral organ uptake
 DPD Scan: no cardiac uptake
 Fat aspirate: no Congo red staining
Other tests
 MRI brain: age appropriate cerebral atrophy
 ECG: normal sinus rhythm
 Echocardiogram: IVSd 1.1 cm. Mild TR. No evidence of cardiac dysfunction.
Genetic testing revealed a recently described Y163X truncation mutation of the gene encoding prion protein (PRNP) [1]. Prion protein is tethered to the cell membrane via a glycosylphosphatidylinositol anchor and the Y163X mutation results in a premature stop codon such that the truncated prion protein is no longer membrane anchored. The PRNP Y163X mutation, follows an autosomal dominant inheritance pattern, presents with adult onset chronic diarrhoea, followed by symptoms of a mixed, predominantly sensory and autonomic neuropathy and late onset cognitive decline and seizures. Pathologically prion protein is deposited throughout peripheral organs primarily the bowel and peripheral nerves, either in between nerve fibres [1] or as ragged deposits in the myelin [2] with significant fibre loss and no evidence of demyelination, and the cortex in the form of amyloid plaques, amyloid angiopathy, tauopathy and unique prion protein fragments. Pan-autonomic failure and peripheral neuropathy is probably due to abnormal prion deposition within the peripheral nervous system. Direct toxic effects of prion protein, deposited in bowel and urinary bladder, may contribute to severe diarrhoea and urinary symptoms. We have not studied adjacent markers on chromosome 20 to define whether there is a common ancestor with the larger pedigree [1].
A 2-bp deletion in codon 178 of PRNP has been described in Japanese kindred causing a familial sensory and autonomic neuropathy with associated cognitive impairment [2]. A different insertional mutation of PRNP resulting in a truncation at position 163 has also been associated with hereditary sensory and autonomic neuropathy [3].
The clinical presentation of prion protein systemic amyloidosis caused by the PRNP Y163X mutation is distinct from previously described forms of hereditary sensory autonomic neuropathy [4] with prominent and early bladder and bowel symptoms, late onset sensory/autonomic neuropathy followed by cognitive involvement. The duration of symptoms and early onset of bowel dysfunction would also be atypical for amyloid neuropathy.
Interesting features of this case include some subtle demyelinating features noted on nerve conduction. Occasional cases of amyloid polyneuropathy have also been reported to show demyelinating changes [5]. Mild conduction slowing could represent direct toxicity of the prion protein on Schwann cells or even prion protein haplo-insufficiency as axonal prion protein has been shown to be required for myelin maintenance in mouse models [6]. This case demonstrates the importance of PRNP analysis, which should be considered in the investigation of unexplained diarrhoea with a sensory neuropathy and is an important differential of familial amyloid polyneuropathy.

Conflicts of interest

On behalf of all authors, the corresponding author states that there is no conflict of interest.

Ethical standard

On behalf of all the authors, the corresponding author states that we acted in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
download
DOWNLOAD
print
DRUCKEN

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

Neuer Inhalt

e.Med Neurologie & Psychiatrie

Kombi-Abonnement

Mit e.Med Neurologie & Psychiatrie erhalten Sie Zugang zu CME-Fortbildungen der Fachgebiete, den Premium-Inhalten der dazugehörigen Fachzeitschriften, inklusive einer gedruckten Zeitschrift Ihrer Wahl.

Weitere Produktempfehlungen anzeigen
Literatur
2.
3.
Zurück zum Zitat Capellari S, Parchi P, Corrado P et al (2014) Prion disease associated with diarrhoea and autonomic neuropathy: phenotypic and genetic characterisation of an Italian family. Poster P.213 Prion, Trieste Capellari S, Parchi P, Corrado P et al (2014) Prion disease associated with diarrhoea and autonomic neuropathy: phenotypic and genetic characterisation of an Italian family. Poster P.213 Prion, Trieste
Metadaten
Titel
Late onset hereditary sensory and autonomic neuropathy with cognitive impairment associated with Y163X prion mutation
verfasst von
Andreas C. Themistocleous
Robin Kennett
Masud Husain
Jacqueline Palace
Simon Mead
David L. H. Bennett
Publikationsdatum
01.11.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Neurology / Ausgabe 11/2014
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-014-7521-6

Weitere Artikel der Ausgabe 11/2014

Journal of Neurology 11/2014 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.